{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:26:41Z","timestamp":1790137601985,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.bmcl.2017.11.040","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T15:00:13Z","timestamp":1511535613000},"page":"134-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Small molecule inhibitors of anthrax edema factor"],"prefix":"10.1016","volume":"28","author":[{"given":"Guan-Sheng","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seongjin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Moayeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Cregar-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"McKasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"O'Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Leppla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2017.11.040_b0005","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"PNAS"},{"key":"10.1016\/j.bmcl.2017.11.040_b0010","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.280.5364.734","article-title":"Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor","volume":"280","author":"Duesbery","year":"1998","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.bmcl.2017.11.040_b0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tim.2014.02.012","article-title":"Anthrax lethal and edema toxins in anthrax pathogenesis","volume":"22","author":"Liu","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bmcl.2017.11.040_b0020","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/infdis\/jis686","article-title":"In vivo germination of Bacillus anthracis spores during murine cutaneous infection","volume":"207","author":"Corre","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmcl.2017.11.040_b0025","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.mam.2009.06.002","article-title":"Anthrax toxins: a weapon to systematically dismantle the host immune defenses","volume":"30","author":"Tournier","year":"2009","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.bmcl.2017.11.040_b0030","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.mam.2009.07.003","article-title":"Cellular and systemic effects of anthrax lethal toxin and edema toxin","volume":"30","author":"Moayeri","year":"2009","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.bmcl.2017.11.040_b0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nature12510","article-title":"Key tissue targets responsible for anthrax-toxin-induced lethality","volume":"501","author":"Liu","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2017.11.040_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/toxins3060721","article-title":"Hemodynamic effects of anthrax toxins in the rabbit model and the cardiac pathology induced by lethal toxin","volume":"3","author":"Lawrence","year":"2011","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bmcl.2017.11.040_b0045","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bmcl.2017.11.040_b0050","doi-asserted-by":"crossref","first-page":"H238","DOI":"10.1152\/ajpheart.00185.2013","article-title":"Anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model","volume":"305","author":"Li","year":"2013","journal-title":"Am J Physiol Heart Circul Physiol"},{"key":"10.1016\/j.bmcl.2017.11.040_b0055","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.celrep.2013.10.019","article-title":"Hijacking multivesicular bodies enables long-term and exosome-mediated long-distance action of anthrax toxin","volume":"5","author":"Abrami","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.bmcl.2017.11.040_b0060","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1086\/512372","article-title":"A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2017.11.040_b0065","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3390\/toxins4111288","article-title":"Pharmacophore selection and redesign of non-nucleotide inhibitors of anthrax edema factor","volume":"4","author":"Schein","year":"2012","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.bmcl.2017.11.040_b0070","doi-asserted-by":"crossref","first-page":"11277","DOI":"10.1073\/pnas.0914611107","article-title":"Use of allostery to identify inhibitors of calmodulin-induced activation of Bacillus anthracis edema factor","volume":"107","author":"Laine","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.bmcl.2017.11.040_b0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pharmthera.2013.07.002","article-title":"Inhibitors of Bacillus anthracis edema factor","volume":"140","author":"Seifert","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmcl.2017.11.040_b0080","doi-asserted-by":"crossref","first-page":"29427","DOI":"10.1074\/jbc.M402689200","article-title":"Structural and kinetic analyses of the interaction of anthrax adenylyl cyclase toxin with reaction products cAMP and pyrophosphate","volume":"279","author":"Guo","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2017.11.040_b0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrd3955","article-title":"Adenosine receptors as drug targets [mdash] what are the challenges?","volume":"12","author":"Chen","year":"2013","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.bmcl.2017.11.040_b0090","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/cmdc.201500469","article-title":"Designing irreversible inhibitors-worth the effort?","volume":"11","author":"Gonzalez-Bello","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2017.11.040_b0095","doi-asserted-by":"crossref","first-page":"13408","DOI":"10.1002\/anie.201601091","article-title":"Targeted covalent inhibitors for drug design","volume":"55","author":"Baillie","year":"2016","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bmcl.2017.11.040_b0100","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4155\/fmc.10.21","article-title":"Strategies for discovering and derisking covalent, irreversible enzyme inhibitors","volume":"2","author":"Johnson","year":"2010","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmcl.2017.11.040_b0105","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1021\/jm3003203","article-title":"Irreversible protein kinase inhibitors: balancing the benefits and risks","volume":"55","author":"Barf","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.11.040_b0110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/415396a","article-title":"Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin","volume":"415","author":"Drum","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2017.11.040_b0115","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1128\/MCB.16.4.1722","article-title":"Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction","volume":"16","author":"Wymann","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bmcl.2017.11.040_b0120","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1021\/ja311729d","article-title":"Aromatic sulfonyl fluorides covalently kinetically stabilize transthyretin to prevent amyloidogenesis while affording a fluorescent conjugate","volume":"135","author":"Grimster","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2017.11.040_b0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/BJ20121014","article-title":"A new family of covalent inhibitors block nucleotide binding to the active site of pyruvate kinase","volume":"448","author":"Morgan","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.bmcl.2017.11.040_b0130","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1002\/anie.200500835","article-title":"Irreversible inhibition of metallo-beta-lactamase (IMP-1) by 3-(3-mercaptopropionylsulfanyl)propionic acid pentafluorophenyl ester","volume":"44","author":"Kurosaki","year":"2005","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bmcl.2017.11.040_b0135","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1021\/jm301205j","article-title":"Sulfonyl fluoride inhibitors of fatty acid amide hydrolase","volume":"55","author":"Alapafuja","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.11.040_b0140","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/S0021-9258(18)50153-8","article-title":"Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase","volume":"237","author":"Kitz","year":"1962","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2017.11.040_b0145","series-title":"Evaluation of enzyme inhibitors in drug discovery: a guide for medicinal chemists and pharmacologists","author":"Copeland","year":"2005"},{"key":"10.1016\/j.bmcl.2017.11.040_b0150","unstructured":"Analogous to the terminology used when describing enzymatic reactions fitting the Michaelis-Menton equation, k(inact) is the maximum rate of enzyme inactivation at infinite inhibitor concentration (cf. k(cat)), and K(I) is the concentration of the inhibitor which results in a reaction rate equal to \u00bd k(inact) (cf. K(M))."},{"key":"10.1016\/j.bmcl.2017.11.040_b0155","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/jm001020e","article-title":"High-throughput permeability pH profile and high-throughput alkane\/water log P with artificial membranes","volume":"44","author":"Wohnsland","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2017.11.040_b0160","doi-asserted-by":"crossref","first-page":"13487","DOI":"10.1073\/pnas.0906581106","article-title":"Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding","volume":"106","author":"Chen","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.bmcl.2017.11.040_b0165","doi-asserted-by":"crossref","first-page":"11262","DOI":"10.1021\/jo401759z","article-title":"Ascertaining the suitability of aryl sulfonyl fluorides for [18F]radiochemistry applications: a systematic investigation using microfluidics","volume":"78","author":"Matesic","year":"2013","journal-title":"J Organ Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17311393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X17311393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:21:37Z","timestamp":1760772097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X17311393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0960894X17311393"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.11.040","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecule inhibitors of anthrax edema factor","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2017.11.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}